A simplified mesoscale 3D model for characterizing fibrinolysis under flow conditions.
Ontology highlight
ABSTRACT: One of the routine clinical treatments to eliminate ischemic stroke thrombi is injecting a biochemical product into the patient's bloodstream, which breaks down the thrombi's fibrin fibers: intravenous or intravascular thrombolysis. However, this procedure is not without risk for the patient; the worst circumstances can cause a brain hemorrhage or embolism that can be fatal. Improvement in patient management drastically reduced these risks, and patients who benefited from thrombolysis soon after the onset of the stroke have a significantly better 3-month prognosis, but treatment success is highly variable. The causes of this variability remain unclear, and it is likely that some fundamental aspects still require thorough investigations. For that reason, we conducted in vitro flow-driven fi
SUBMITTER: Petkantchin R
PROVIDER: S-EPMC10444897 | biostudies-literature | 2023 Aug
REPOSITORIES: biostudies-literature
ACCESS DATA